Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of New FluMist Strains for 2013-2014 Season
NCT01859143Phase 4Completed
- Sponsor
- MedImmune
- Start
- May 2013
- Primary completion
- Dec 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in influenza comparing Trivalent Influenza Vaccine with Placebo (2 arms). Primary endpoint: Percentage of Participants With Fever Greater Than or Equal to 101 Degrees Fahrenheit at 7 days. Started May 2013; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01859143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01859143.